GW Pharma (GWPH) PT Raised to $164 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GW Pharma (GWPH) Tops Q2 EPS by 61c, Revenues Beat
August 6, 2020 4:01 PM EDTGW Pharma (NASDAQ: GWPH) reported Q2 EPS of ($0.02), $0.61 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $121.3 million versus the consensus estimate of $120.31 million.
FINANCIAL RESULTS
Total revenue for the quarter ended June 30, 2020 was $121.3 million compared to $72.0 million for the quarter ended June 30, 2019Net... More